xinyaqiang(603155)

Search documents
新亚强:关于召开2022年度业绩说明会的公告
2023-04-18 08:34
证券代码:603155 证券简称:新亚强 公告编号:2023-006 新亚强硅化学股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 会议召开时间:2023 年 4 月 27 日(星期四) 15:00-16:00 会 议 召 开 地 点 : 上海证券 交易所上证路演中心( 网 址 : http://roadshow.sseinfo.com/) 会议召开方式:上证路演中心网络互动 投资者可于 2023 年 4 月 20 日(星期四) 至 4 月 26 日(星期三)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过 公司邮箱 ir@newasiaman.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 新亚强硅化学股份有限公司(以下简称"公司")将于 2023 年 4 月 25 日发 布公司 2022 年度报告,为便于广大投资者更全面深入地了解公司 2022 年度经营 成果、财务状况,公司计划于 2023 年 4 月 2 ...
新亚强(603155) - 2022 Q3 - 季度财报
2022-10-27 16:00
Financial Performance - The company's operating revenue for Q3 2022 was ¥275,216,940.24, representing a 25.68% increase compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2022 was ¥73,608,275.59, showing a decrease of 10.88% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥69,101,543.48, down by 9.00% compared to the previous year[3]. - The basic earnings per share for Q3 2022 was ¥0.33, a decrease of 10.81% compared to the same period last year[3]. - The net profit for Q3 2022 was CNY 264,742,592.84, an increase of 15.4% compared to CNY 229,355,399.95 in Q3 2021[19]. - The total comprehensive income for Q3 2022 was CNY 264,742,592.84, an increase from CNY 229,355,399.95 in Q3 2021, representing a growth of 15.4%[20]. - Net profit for the first three quarters of 2022 was ¥264,289,219.25, up 15.2% from ¥229,355,399.95 in the previous year[30]. Revenue and Costs - Total operating revenue for the first three quarters of 2022 reached RMB 940,585,075.66, a significant increase from RMB 633,377,672.84 in the same period of 2021, representing a growth of approximately 48.4%[18]. - Total operating costs for the first three quarters of 2022 were RMB 666,842,810.04, compared to RMB 402,619,339.76 in the first three quarters of 2021, indicating an increase of about 65.7%[18]. - The total revenue for the first three quarters of 2022 reached ¥940,578,279.27, a significant increase of 48.4% compared to ¥633,377,672.84 in the same period of 2021[29]. Cash Flow - The cash flow from operating activities for the year-to-date period reached ¥256,423,754.46, an increase of 97.85%[3]. - The cash flow from operating activities for the first three quarters of 2022 was CNY 256,423,754.46, significantly higher than CNY 129,608,275.50 in the same period of 2021, marking a growth of 97.9%[22]. - The cash flow from investing activities showed a net inflow of CNY 38,903,485.43 in Q3 2022, a recovery from a net outflow of CNY -207,863,706.39 in Q3 2021[23]. - The net cash flow from operating activities for the first three quarters of 2022 was approximately ¥256.49 million, a 98% increase compared to ¥129.61 million in the same period of 2021[32]. - The net cash flow from investment activities for Q3 2022 was approximately ¥20.72 million, a significant improvement from a negative cash flow of ¥207.86 million in Q3 2021[33]. Assets and Liabilities - The total assets at the end of Q3 2022 were ¥2,707,557,913.27, an increase of 8.07% from the end of the previous year[4]. - Total assets as of September 30, 2022, were RMB 2,707,557,913.27, up from RMB 2,505,486,058.34 at the end of 2021, representing an increase of approximately 8.1%[15]. - Total liabilities as of September 30, 2022, were RMB 367,937,438.98, compared to RMB 305,048,176.89 at the end of 2021, indicating an increase of about 20.7%[14]. - The total liabilities as of September 30, 2022, were ¥367,908,796.97, compared to ¥305,043,169.84 at the end of 2021, indicating an increase of 20.6%[27]. Shareholder Information - The company had a total of 15,243 common shareholders at the end of the reporting period[8]. - The top shareholder, Chulin, held 45.99% of the shares, totaling 103,725,189 shares[9]. Research and Development - Research and development expenses for the first three quarters of 2022 amounted to RMB 26,084,397.73, up from RMB 19,532,144.91 in the same period of 2021, reflecting a growth of approximately 33.4%[18]. - Research and development expenses for the first three quarters of 2022 were ¥26,084,397.73, up 33.4% from ¥19,532,144.91 in 2021, highlighting a commitment to innovation[29]. Future Strategies - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the provided content[18]. - The company has plans for future growth strategies, including potential mergers and acquisitions, although specific details were not provided in the content[18].
新亚强(603155) - 2022 Q2 - 季度财报
2022-08-25 16:00
[Definitions](index=4&type=section&id=Item%201.%20Definitions) This section provides definitions of key terms used in the report [Company Profile and Key Financial Indicators](index=4&type=section&id=Item%202.%20Company%20Profile%20and%20Key%20Financial%20Indicators) This section provides an overview of the company's basic information and key financial performance metrics [Company Basic Information](index=4&type=section&id=I.%20Company%20Information) Xinyaqiang Silicon Chemical Co., Ltd. (Xinyaqiang) specializes in the R&D, production, and sales of organosilicon fine chemicals, with Chu Yajun as its legal representative, and its registered address changed during the reporting period - The company's Chinese name is Xinyaqiang Silicon Chemical Co., Ltd., stock code **603155**, listed on the Shanghai Stock Exchange[11](index=11&type=chunk)[16](index=16&type=chunk) - During the reporting period, the company's registered address changed from 'No. 3 Jingwu Road, Suqian Ecological Chemical Industry Park' to 'No. 2 Yangzi Road, Suqian Ecological Chemical Industry Park'[13](index=13&type=chunk) [Key Accounting Data and Financial Indicators](index=5&type=section&id=VII.%20Key%20Accounting%20Data%20and%20Financial%20Indicators) In the first half of 2022, the company achieved strong performance growth, with revenue increasing by **60.56%** to **665.37 million Yuan** and net profit attributable to shareholders rising by **30.23%** to **191.12 million Yuan**, driven by higher product prices and sales volumes Key Accounting Data for H1 2022 | Key Accounting Data | Current Period (Jan-Jun) (Yuan) | Prior Period (Yuan) | YoY Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 665,368,135.42 | 414,393,998.89 | 60.56 | | Net Profit Attributable to Listed Company Shareholders | 191,120,801.78 | 146,757,676.14 | 30.23 | | Net Profit Attributable to Listed Company Shareholders (Excluding Non-recurring Items) | 179,524,620.74 | 132,608,674.55 | 35.38 | | Net Cash Flow from Operating Activities | 193,256,420.35 | 59,681,746.53 | 223.81 | | **Indicator** | **Current Period End (Yuan)** | **Prior Year End (Yuan)** | **YoY Change (%)** | | Net Assets Attributable to Listed Company Shareholders | 2,235,998,683.23 | 2,200,437,881.45 | 1.62 | | Total Assets | 2,633,812,405.96 | 2,505,486,058.34 | 5.12 | Key Financial Indicators for H1 2022 | Key Financial Indicators | Current Period (Jan-Jun) | Prior Period | Change | | :--- | :--- | :--- | :--- | | Basic Earnings Per Share (Yuan/share) | 0.85 | 0.65 | Growth 30.77% | | Basic Earnings Per Share (Excluding Non-recurring Items) (Yuan/share) | 0.80 | 0.59 | Growth 35.59% | | Weighted Average Return on Net Assets (%) | 8.52 | 7.19 | Increase 1.33 percentage points | | Weighted Average Return on Net Assets (Excluding Non-recurring Items) (%) | 8.00 | 6.50 | Increase 1.50 percentage points | - The growth in the company's revenue and profit indicators is primarily attributed to the increase in product prices and sales volumes during the reporting period[20](index=20&type=chunk) [Non-recurring Gains and Losses](index=6&type=section&id=IX.%20Non-recurring%20Gains%20and%20Losses%20and%20Amounts) In the first half of 2022, the company's total non-recurring gains and losses amounted to **11.60 million Yuan**, primarily driven by fair value changes and investment income from financial assets totaling **13.52 million Yuan** Details of Non-recurring Gains and Losses | Non-recurring Item | Amount (Yuan) | | :--- | :--- | | Non-current asset disposal gains and losses | -136,619.63 | | Government grants recognized in current profit or loss | 1,170,586.02 | | Fair value changes and investment income from trading financial assets, etc | 13,519,422.35 | | Other non-operating income and expenses | -1,000,000.00 | | Other non-recurring items as defined | 136,119.37 | | **Less: Income tax impact** | **2,093,327.07** | | **Total** | **11,596,181.04** | [Management Discussion and Analysis](index=7&type=section&id=Item%203.%20Management%20Discussion%20and%20Analysis) This section provides an in-depth analysis of the company's operations, financial condition, and future outlook [Industry and Main Business](index=7&type=section&id=I.%20Description%20of%20Industry%20and%20Main%20Business%20during%20the%20Reporting%20Period) The company specializes in the R&D, production, and sales of organosilicon fine chemicals, primarily offering organosilicon functional additives and phenylchlorosilanes for various industries including new materials, pharmaceuticals, and electronics - The company's main business is organosilicon fine chemicals, with products categorized into organosilicon functional additives and phenylchlorosilanes[24](index=24&type=chunk) - Functional additive products include methyl series (hexamethyldisilazane, silyl ether) and vinyl series (vinyl disilazane), serving as key materials for silicone rubber, pharmaceutical synthesis, semiconductor industry, and lithium battery electrolytes[25](index=25&type=chunk) - Phenylchlorosilane products are crucial raw materials for producing special organosilicon materials like phenyl silicone rubber, silicone resin, and silicone oil, which exhibit excellent performance in high/low temperature resistance and radiation resistance[25](index=25&type=chunk) [Core Competencies](index=7&type=section&id=II.%20Analysis%20of%20Core%20Competencies%20during%20the%20Reporting%20Period) The company's core competencies include advanced processes, comprehensive product services, strong R&D innovation, integrated industrial chain, and a reputable market brand, with leading domestic market share and patented technologies - The company possesses self-developed core patented technologies, including solvent-free hexamethyldisilazane, new vinyl special monomers, and direct phenylchlorosilane production, ensuring outstanding product quality and leading domestic market share and export volume[26](index=26&type=chunk) - The company provides multi-variety product portfolio solutions tailored to customer needs, fostering long-term and stable client relationships[27](index=27&type=chunk) - The company has established multiple provincial R&D centers, collaborates with universities for industry-academia-research initiatives, holds **47 patents**, and its hexamethyldisilazane product is recognized as a manufacturing single champion product[27](index=27&type=chunk) - The company continuously extends its organosilicon industry chain upstream and downstream, enhances comprehensive utilization of by-products, builds a circular economy, and improves profitability and market competitiveness[28](index=28&type=chunk) [Discussion and Analysis of Operations](index=8&type=section&id=III.%20Discussion%20and%20Analysis%20of%20Operations) In H1 2022, the company maintained steady growth in key operating indicators, with revenue reaching **665.37 million Yuan** and net profit **191.12 million Yuan**, while new projects like the 10,000-ton phenylchlorosilane (Phase II) facility successfully commenced operations - During the reporting period, the company overcame adverse impacts such as the pandemic, rising raw material, and logistics costs, maintaining steady growth in key operating indicators[29](index=29&type=chunk) - Progress was made in the company's new project construction, with the successful commissioning of the **10,000-ton/year** phenylchlorosilane (Phase II) and **2,500-ton/year** phenyl intermediate projects, solidifying the company's advantageous position in the organosilicon sub-segment[29](index=29&type=chunk) Key Performance Indicators for H1 2022 | Indicator | Amount (10,000 Yuan) | YoY Growth (%) | | :--- | :--- | :--- | | Operating Revenue | 66,536.81 | 60.56 | | Net Profit Attributable to Listed Company Shareholders | 19,112.08 | 30.23 | | Net Profit Attributable to Listed Company Shareholders (Excluding Non-recurring Items) | 17,952.46 | 35.38 | | Earnings Per Share (Yuan) | 0.85 | 30.77 | [Main Business Analysis](index=9&type=section&id=(I)%20Main%20Business%20Analysis) During the reporting period, the company's main business revenue increased by **60.56%** due to higher product prices and sales, while operating costs rose by **87.34%** due to increased raw material and logistics expenses, and financial expenses significantly decreased due to exchange gains Analysis of Major Financial Statement Items | Item | Current Period Amount (Yuan) | Prior Period Amount (Yuan) | Change (%) | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 665,368,135.42 | 414,393,998.89 | 60.56 | Increase in product prices and sales volumes | | Operating Cost | 449,223,947.05 | 239,789,563.40 | 87.34 | Increase in raw material prices and logistics costs | | Financial Expenses | -12,728,969.43 | 234,157.41 | -5,536.07 | Exchange gains | | Net Cash Flow from Operating Activities | 193,256,420.35 | 59,681,746.53 | 223.81 | Increase in cash received from sales of goods | [Analysis of Assets and Liabilities](index=9&type=section&id=(III)%20Analysis%20of%20Assets%20and%20Liabilities) As of the end of the reporting period, total assets were **2.63 billion Yuan**, with cash increasing by **48.49%** due to redemption of financial assets, and construction in progress rising by **53.95%** due to ongoing project investments Changes in Major Assets and Liabilities | Item Name | Current Period End Amount (Yuan) | Prior Year End Amount (Yuan) | Change (%) | Explanation | | :--- | :--- | :--- | :--- | :--- | | Cash and Bank Balances | 351,305,891.11 | 236,578,797.47 | 48.49 | Primarily due to redemption of trading financial assets | | Construction in Progress | 168,086,726.17 | 109,182,691.54 | 53.95 | Primarily due to increased investment in ongoing projects during the period | | Short-term Borrowings | 13,300,000.00 | 0.00 | 100.00 | Primarily due to increased bank borrowings during the period | | Contract Liabilities | 3,793,481.00 | 6,632,371.78 | -42.80 | Primarily due to decrease in advance receipts during the period | [Analysis of Investment Status](index=10&type=section&id=(IV)%20Analysis%20of%20Investment%20Status) During the reporting period, the company's external equity investments totaled **107 million Yuan**, a **100%** increase, including a planned **400 million Yuan** joint venture with Hubei Xingrui Silicon Material Co., Ltd., which is yet to be established - The company plans to invest **400 million Yuan** to establish a joint venture with Hubei Xingrui Silicon Material Co., Ltd. to expand its business layout[38](index=38&type=chunk) - As of June 30, 2022, the company's financial assets measured at fair value totaled **1.25 billion Yuan**, primarily comprising trading financial assets and accounts receivable financing[40](index=40&type=chunk) [Analysis of Major Holding and Participating Companies](index=11&type=section&id=(VI)%20Analysis%20of%20Major%20Holding%20and%20Participating%20Companies) The company's main wholly-owned subsidiary, Xinyaqiang (Shanghai) Silicon Material Co., Ltd., engaged in R&D and trade, reported a net profit of **0.27 million Yuan** during the period Key Financial Data of Xinyaqiang (Shanghai) Silicon Material Co., Ltd. (Unit: 10,000 Yuan) | Total Assets | Net Assets | Operating Revenue | Net Profit | | :--- | :--- | :--- | :--- | | 12,051.29 | 12,027.22 | 14.16 | 26.53 | [Risk Warnings](index=11&type=section&id=(I)%20Potential%20Risks) The company faces risks including intensified market competition, macroeconomic and market environment changes, safety production, environmental protection, technological R&D, and significant international environment shifts - Risk of intensified market competition: Entry of dominant industry players into the company's key product segments may lead to capacity expansion and price declines[43](index=43&type=chunk) - Safety production and environmental risks: The company's production involves hazardous chemicals, posing potential safety accidents; stricter environmental regulations may increase operating costs[44](index=44&type=chunk) - Technology R&D risk: New product development involves long cycles and high costs, and failure to develop or adapt to market demand could adversely affect operations[45](index=45&type=chunk) - Risk of significant international environmental changes: Recurring global pandemics and geopolitical conflicts may lead to rising commodity prices, disrupted international logistics, and significant exchange rate fluctuations[46](index=46&type=chunk) [Corporate Governance](index=12&type=section&id=Item%204.%20Corporate%20Governance) This section details changes in the company's board, supervisors, and senior management, as well as its profit distribution plan [Changes in Directors, Supervisors, and Senior Management](index=12&type=section&id=II.%20Changes%20in%20the%20Company's%20Directors%2C%20Supervisors%2C%20and%20Senior%20Management) During the reporting period, the company's director and deputy general manager, Mr. Chu Yaxian, passed away, leading to changes in the board and senior management - Mr. Chu Yaxian, former director and deputy general manager, resigned due to illness and passing[49](index=49&type=chunk)[50](index=50&type=chunk) [Profit Distribution Plan](index=13&type=section&id=III.%20Profit%20Distribution%20or%20Capital%20Reserve%20to%20Share%20Capital%20Plan) The company proposes no profit distribution or capital reserve capitalization for the first half of 2022 - The H1 2022 profit distribution plan proposes no distribution and no capitalization from capital reserves[51](index=51&type=chunk) [Environmental and Social Responsibility](index=13&type=section&id=Item%205.%20Environmental%20and%20Social%20Responsibility) This section outlines the company's environmental protection measures and its contributions to social welfare initiatives [Environmental Information](index=13&type=section&id=(I)%20Environmental%20Information%20for%20Companies%20and%20Major%20Subsidiaries%20Designated%20as%20Key%20Pollution%20Units%20by%20Environmental%20Protection%20Authorities) As a key pollution unit, the company operates wastewater treatment and incineration facilities, adheres to environmental regulations, and reported no excessive emissions or administrative penalties during the period - The company has established wastewater treatment systems and incineration facilities for waste gas, liquid, and residue, ensuring all emissions meet standards after treatment[55](index=55&type=chunk) - The company strictly implements environmental impact assessment and the 'three simultaneous' system, and has filed its 'Emergency Plan for Environmental Incidents' with environmental authorities[56](index=56&type=chunk)[57](index=57&type=chunk) - During the reporting period, the company received no administrative penalties for environmental issues[59](index=59&type=chunk) [Social Responsibility](index=15&type=section&id=II.%20Specific%20Information%20on%20Consolidating%20Poverty%20Alleviation%20Achievements%20and%20Rural%20Revitalization) During the reporting period, the company actively fulfilled its social responsibilities by donating **1 million Yuan** for epidemic prevention and contributing books to local community libraries - In April 2022, the company donated **1 million Yuan** for epidemic prevention to Jilin City[60](index=60&type=chunk) - In June 2022, the company donated books to Yubei Community to support the construction of local rural libraries[60](index=60&type=chunk) [Significant Matters](index=16&type=section&id=Item%206.%20Significant%20Matters) This section details the fulfillment of commitments made by the company and its related parties during the initial public offering [Fulfillment of Commitments](index=16&type=section&id=I.%20Fulfillment%20of%20Commitments) During the reporting period, the company's actual controllers, shareholders, and D&O strictly fulfilled their commitments made during the IPO, including share lock-up, reduction intentions, and share price stabilization plans - The company's controlling shareholder, actual controllers, shareholders holding **5%** or more, and D&O have strictly fulfilled their share lock-up commitments since the company's listing on September 1, 2020, with a lock-up period of **36 months**[63](index=63&type=chunk)[64](index=64&type=chunk)[65](index=65&type=chunk)[68](index=68&type=chunk)[70](index=70&type=chunk)[71](index=71&type=chunk) - The company, its actual controllers, and D&O have formulated a share price stabilization plan for the three years post-listing, to be activated if the share price falls below net asset value per share, including company buybacks, and increased holdings by actual controllers and D&O[74](index=74&type=chunk)[75](index=75&type=chunk)[76](index=76&type=chunk)[77](index=77&type=chunk)[78](index=78&type=chunk) [Share Changes and Shareholder Information](index=25&type=section&id=Item%207.%20Share%20Changes%20and%20Shareholder%20Information) This section provides details on changes in the company's share capital, shareholder structure, and changes in controlling shareholders or actual controllers [Share Capital Changes](index=25&type=section&id=I.%20Share%20Capital%20Changes) During the reporting period, the company's total share capital increased from **155.56 million** shares to **225.56 million** shares due to a capital reserve capitalization plan of **4.5** shares for every **10** shares - The company implemented a capital reserve capitalization plan of **4.5** shares for every **10** shares, increasing total share capital from **155,560,000** shares to **225,562,000** shares[92](index=92&type=chunk)[93](index=93&type=chunk) [Shareholder Information](index=27&type=section&id=II.%20Shareholder%20Information) As of the reporting period end, the company had **15,458** common shareholders, with Chu Lin (**45.99%**) and Hongta Innovation (Kunshan) Venture Capital Co., Ltd. (**12.63%**) as the top two shareholders - As of the end of the reporting period, the company had a total of **15,458** shareholders[97](index=97&type=chunk) Top Ten Shareholders' Shareholding | Shareholder Name | Shares Held at Period End (shares) | Proportion (%) | Nature of Shares | | :--- | :--- | :--- | :--- | | Chu Lin | 103,725,189 | 45.99 | Domestic Natural Person | | Hongta Innovation (Kunshan) Venture Capital Co., Ltd. | 28,482,799 | 12.63 | State-owned Legal Person | | Hongta Innovation Investment Co., Ltd. | 16,377,445 | 7.26 | State-owned Legal Person | | Sun Xiujie | 14,241,403 | 6.31 | Domestic Natural Person | | Huaxia Life Insurance Co., Ltd. - Proprietary Funds | 5,851,765 | 2.59 | Unknown | | National Social Security Fund 503 Portfolio | 5,399,995 | 2.39 | Unknown | | Chu Yajun | 3,444,664 | 1.53 | Domestic Natural Person | [Change in Controlling Shareholder or Actual Controller](index=30&type=section&id=IV.%20Change%20in%20Controlling%20Shareholder%20or%20Actual%20Controller) The company's actual controllers changed on June 7, 2022, with Ms. Sun Xiujie inheriting shares from the deceased Mr. Chu Yaxian, dissolving the previous concerted action relationship, and establishing Chu Lin as the controlling shareholder, and Chu Yajun and Chu Lin as the actual controllers - The company's actual controllers changed on **June 7, 2022**, with the new actual controllers being Chu Yajun and Chu Lin[106](index=106&type=chunk) [Preferred Shares Information](index=30&type=section&id=Item%208.%20Preferred%20Shares%20Information) This section confirms that the company has no preferred shares during the reporting period [Preferred Shares](index=30&type=section&id=Item%208.%20Preferred%20Shares%20Information) The company has no preferred shares during the reporting period - Not applicable[108](index=108&type=chunk) [Bonds Information](index=30&type=section&id=Item%209.%20Bonds%20Information) This section confirms that the company has no bond-related information during the reporting period [Bonds](index=30&type=section&id=Item%209.%20Bonds%20Information) The company has no corporate bonds, company bonds, non-financial enterprise debt financing instruments, or convertible bonds during the reporting period - Not applicable[109](index=109&type=chunk)[110](index=110&type=chunk) [Financial Report](index=32&type=section&id=Item%2010.%20Financial%20Report) This section presents the company's unaudited financial statements, including key balance sheet, income statement, and cash flow data for the reporting period [Financial Statement Overview](index=32&type=section&id=II.%20Financial%20Statements) This semi-annual report's financial statements are unaudited; as of June 30, 2022, total assets were **2.63 billion Yuan**, owner's equity **2.24 billion Yuan**, with H1 2022 total revenue **665.37 million Yuan** (**60.56%** YoY growth), net profit **191.12 million Yuan** (**30.23%** YoY growth), and net cash flow from operating activities **193.26 million Yuan** (**223.81%** YoY growth) - This semi-annual report is unaudited[7](index=7&type=chunk)[112](index=112&type=chunk) Consolidated Financial Statement Core Data (Unit: Yuan) | Item | June 30, 2022 / Jan-Jun 2022 | Dec 31, 2021 / Jan-Jun 2021 | | :--- | :--- | :--- | | **Balance Sheet** | | | | Total Assets | 2,633,812,405.96 | 2,505,486,058.34 | | Total Liabilities | 397,813,722.73 | 305,048,176.89 | | Total Owner's Equity Attributable to Parent Company | 2,235,998,683.23 | 2,200,437,881.45 | | **Income Statement** | | | | Total Operating Revenue | 665,368,135.42 | 414,393,998.89 | | Total Operating Costs | 464,880,432.42 | 264,582,729.56 | | Net Profit | 191,120,801.78 | 146,757,676.14 | | **Cash Flow Statement** | | | | Net Cash Flow from Operating Activities | 193,256,420.35 | 59,681,746.53 | | Net Cash Flow from Investing Activities | 32,575,774.64 | -144,946,564.93 | | Net Cash Flow from Financing Activities | -142,282,809.50 | -80,952,745.50 | [Taxation](index=73&type=section&id=VI.%20Taxation) The company's main taxes include VAT (**13%**) and Urban Maintenance and Construction Tax (**7%**), benefiting from a **15%** corporate income tax rate as a high-tech enterprise and a **13%** export tax refund rate - The company is recognized as a high-tech enterprise, valid for three years (2021-2023), enjoying a preferential corporate income tax rate of **15%**[241](index=241&type=chunk) - The company's export goods are subject to a tax exemption, offset, and refund management method, with a refund rate of **13%**[242](index=242&type=chunk) [Summary of Notes to Consolidated Financial Statements](index=74&type=section&id=VII.%20Notes%20to%20Consolidated%20Financial%20Statements) At period-end, trading financial assets totaled **1.24 billion Yuan**, primarily structured deposits and bank wealth management products, while construction in progress was **168 million Yuan**, mainly for phenyl intermediate and silicone resin projects - As of the end of the period, the company's trading financial assets balance was **1.24 billion Yuan**, primarily consisting of structured deposits and bank wealth management products[245](index=245&type=chunk) - The balance of construction in progress at period-end was **168 million Yuan**, primarily invested in the phenyl intermediate project (**140 million Yuan**) and the phenyl silicone resin project (**26 million Yuan**)[290](index=290&type=chunk) H1 2022 Operating Revenue Composition | Product Type | Operating Revenue (Yuan) | | :--- | :--- | | Functional Additives | 562,776,674.49 | | Phenylchlorosilane | 80,741,078.43 | | Other Businesses | 21,850,382.50 | | **Total** | **665,368,135.42** | - During the reporting period, the company's financial expenses were **-12.73 million Yuan**, primarily due to exchange gains of **11.65 million Yuan**[343](index=343&type=chunk) [Supplementary Information](index=129&type=section&id=XVIII.%20Supplementary%20Information) During the reporting period, the company's total non-recurring gains and losses amounted to **11.60 million Yuan**, with a weighted average return on net assets of **8.52%** and basic earnings per share of **0.85 Yuan** Return on Net Assets and Earnings Per Share | Profit for the Reporting Period | Weighted Average Return on Net Assets (%) | Basic Earnings Per Share (Yuan) | | :--- | :--- | :--- | | Net Profit Attributable to Common Shareholders of the Company | 8.52 | 0.85 | | Net Profit Attributable to Common Shareholders of the Company (Excluding Non-recurring Items) | 8.00 | 0.80 |
新亚强(603155) - 2022 Q1 - 季度财报
2022-04-28 16:00
2022 年第一季度报告 证券代码:603155 证券简称:新亚强 新亚强硅化学股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 1、公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、 准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责 任。 2、公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季 度报告中财务报表信息的真实、准确、完整。 3、第一季度财务报表是否经审计 □是 √否 一、主要财务数据 □适用 √不适用 2022 年第一季度报告 (三)主要会计数据、财务指标发生变动的情况、原因 √适用 □不适用 | 项目名称 | 变动比例(%) | 主要原因 | | --- | --- | --- | | 营业收入 | 70.25 | 主要是受原材料价格上涨和市场需求向好 影响,主要产品价格和销量均有所增长。 | | 归属于上市公司股东的净利润 | 35.39 | 主要是营业收入增长所致。 | | 归属于上市公司股 ...
新亚强(603155) - 2021 Q4 - 年度财报
2022-03-30 16:00
Financial Performance - The company's operating revenue for 2021 was CNY 879,996,006.51, representing a 79.47% increase compared to CNY 490,329,112.07 in 2020[22]. - Net profit attributable to shareholders for 2021 reached CNY 319,444,551.13, a 103.03% increase from CNY 157,336,401.16 in 2020[22]. - The net profit after deducting non-recurring gains and losses was CNY 291,373,246.30, up 118.96% from CNY 133,073,660.69 in 2020[22]. - The company's total assets increased by 19.05% to CNY 2,505,486,058.34 at the end of 2021, compared to CNY 2,104,591,662.00 at the end of 2020[22]. - Basic earnings per share for 2021 were CNY 2.05, a 69.42% increase from CNY 1.21 in 2020[23]. - The weighted average return on equity rose to 15.38% in 2021, an increase of 1.16 percentage points from 14.22% in 2020[23]. - The net cash flow from operating activities for 2021 was CNY 190,468,110.19, a 24.03% increase from CNY 153,571,836.86 in 2020[22]. - The company reported a quarterly revenue of CNY 246,618,333.67 in Q4 2021, showing consistent growth throughout the year[25]. - The company's net assets attributable to shareholders increased by 11.89% to CNY 2,200,437,881.45 at the end of 2021, up from CNY 1,966,551,330.32 at the end of 2020[22]. Dividend and Capital Management - The company plans to distribute a cash dividend of 10.00 RMB per 10 shares, totaling 155,560,000.00 RMB (including tax) based on a total share capital of 155,560,000 shares[6]. - The company will also increase capital reserves by issuing 4.5 additional shares for every 10 shares held by shareholders[6]. - The company approved a cash dividend of 10.00 CNY per 10 shares, totaling 155,560,000.00 CNY, which represents 48.70% of the net profit attributable to shareholders for the year 2021[130]. Audit and Compliance - The company has received a standard unqualified audit report from Zhongshun Zhonghuan Accounting Firm[5]. - The audit report confirms that the financial statements of Xinyaqiang Silicon Chemical Co., Ltd. fairly reflect its financial position as of December 31, 2021, in accordance with accounting standards[200]. - The audit opinion indicates that the financial statements are free from material misstatement and provide a true and fair view of the company's financial results[200]. - The company is committed to adhering to enterprise accounting standards in its financial reporting[200]. - The company has established a robust corporate governance structure, ensuring compliance with relevant laws and regulations[98]. Research and Development - The company added 19 new authorized patents during the reporting period, contributing to sustainable high-quality development[32]. - The company’s R&D efforts led to the establishment of a new research center in Shanghai, enhancing innovation capabilities[38]. - R&D expenses increased by 56.16% to CNY 28,158,869.81, representing 3.20% of total operating revenue[54]. - The company is actively expanding its product lines in the organic silicon industry, focusing on high-end applications[38]. - The company is committed to strengthening collaboration with universities and research institutions to enhance the relevance and foresight of product development[91]. Market and Competitive Position - The company’s market share for key products has further increased, particularly in high-growth sectors such as new energy and new materials[33]. - The company faces intensified market competition due to the rapid growth of domestic organic silicon enterprises and potential price declines[92]. - The company anticipates continued rapid growth in product prices and market demand due to the expansion of strategic emerging industries such as new energy vehicles and 5G technology[89]. - The company is a leading manufacturer in the organic silicon functional additives and phenyl chlorosilane products sector, with strong market competitiveness and recognition from international giants[66]. Environmental and Social Responsibility - The company has obtained ISO 14001:2015 certification for its environmental management system, emphasizing its commitment to environmental protection[94]. - The company has established a wastewater treatment system that complies with discharge standards, utilizing MVR evaporation and biochemical treatment processes[139]. - The company actively fulfills its social responsibilities, focusing on integrity, compliance, safety, and environmental protection[146]. Investor Relations and Governance - The company emphasizes transparency in information disclosure, ensuring all shareholders have equal access to information[100]. - The company has established a dedicated department for daily investor relations management, ensuring compliance and transparency in investor communications[101]. - The company has conducted multiple shareholder meetings to discuss annual reports and financial decisions, ensuring shareholder engagement[102]. - The company has a structured approach to managing its investor relations, which is expected to enhance governance and maximize overall corporate benefits[101]. Financial Management and Investments - The company has engaged in wealth management with a total investment of RMB 367,700,000, including RMB 153,200,000 from self-owned funds and RMB 214,500,000 from raised funds[172]. - The company has a diversified investment strategy, utilizing both fixed income and floating income types in its financial management[180]. - The total amount of entrusted financial management by China Bank in 2021 reached CNY 20,500 million, with a minimum return type and an annualized yield of 1.50%[176]. - The actual return or loss for the entrusted financial management by China Bank was CNY 388.07 million, reflecting a loss of -3.97%[176]. Future Outlook - The company plans to enhance its production capacity and accelerate technological innovation in 2022, focusing on semiconductor, new energy, and high-end new materials applications[91]. - The company has set a performance guidance of 10% revenue growth for 2022, driven by new product launches and market expansion[107]. - The management team emphasized the importance of digital transformation, with a target of increasing online sales by 25%[107].
新亚强(603155) - 2021 Q3 - 季度财报
2021-10-28 16:00
2021 年第三季度报告 证券代码:603155 证券简称:新亚强 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整, 不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务 报表信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 项目 本报告期 本报告期 比上年同 期增减变 动幅度(%) 年初至报告期 末 年初至报告期 末比上年同期 增减变动幅度 (%) 营业收入 218,983,673.95 85.24 633,377,672.84 75.92 归属于上市公司股东的 净利润 82,597,723.81 124.18 229,355,399.95 87.65 归属于上市公司股东的 扣除非经常性损益的净 利润 75,939,099.92 166.94 208,547,774.47 83.16 经营活动产生的现金流 量净额 不适用 不适用 129,608,275.50 -21.87 基本每股收益(元/ 股) 0.53 89.2 ...
新亚强(603155) - 2021 Q2 - 季度财报
2021-07-30 16:00
[Definitions](index=4&type=section&id=Definitions) [Company Profile and Key Financial Indicators](index=4&type=section&id=Company%20Profile%20and%20Key%20Financial%20Indicators) [Company Information and Basic Overview](index=4&type=section&id=Company%20Information%20and%20Basic%20Overview) Xinyaqiang Silicon Chemical Co., Ltd. (Xinyaqiang) is a Shanghai-listed company (603155) with its legal and operational base in Suqian, Jiangsu | Item | Information | | :--- | :--- | | **Company Chinese Name** | 新亚强硅化学股份有限公司 | | **Stock Abbreviation** | 新亚强 | | **Stock Code** | 603155 | | **Listing Exchange** | 上海证券交易所 | | **Legal Representative** | 初亚军 | [Key Accounting Data and Financial Indicators](index=5&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) In H1 2021, the company saw over **71%** growth in revenue and net profit due to strong demand, despite a **41.23%** decrease in operating cash flow | Key Accounting Data | Current Period (Jan-Jun) | Prior Period | YoY Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 414.39 Million Yuan | 241.81 Million Yuan | 71.37% | | Net Profit Attributable to Shareholders of Listed Company | 146.76 Million Yuan | 85.38 Million Yuan | 71.88% | | Net Profit Attributable to Shareholders of Listed Company (Excluding Non-recurring Items) | 132.61 Million Yuan | 85.41 Million Yuan | 55.26% | | Net Cash Flow from Operating Activities | 59.68 Million Yuan | 101.55 Million Yuan | -41.23% | | **Asset Status** | **End of Current Period** | **End of Prior Year** | **Period-end vs. Prior Year-end Change (%)** | | Net Assets Attributable to Shareholders of Listed Company | 2,028.26 Million Yuan | 1,966.55 Million Yuan | 3.14% | | Total Assets | 2,157.17 Million Yuan | 2,104.59 Million Yuan | 2.50% | | Key Financial Indicators | Current Period (Jan-Jun) | Prior Period | YoY Change (%) | | :--- | :--- | :--- | :--- | | Basic Earnings Per Share (Yuan/Share) | 0.94 | 0.73 | 28.77% | | Diluted Earnings Per Share (Yuan/Share) | 0.94 | 0.73 | 28.77% | | Weighted Average Return on Net Assets (%) | 7.19% | 12.39% | Decreased by 5.20 percentage points | - The company stated that the significant growth in operating revenue and net profit in the first half of 2021 was primarily due to strong market demand for main products and a substantial increase in product sales compared to the same period last year[20](index=20&type=chunk) [Non-recurring Gains and Losses and Amounts](index=6&type=section&id=Non-recurring%20Gains%20and%20Losses%20and%20Amounts) Non-recurring gains and losses totaled **14.15 Million Yuan**, mainly from fair value changes in financial assets and entrusted investments | Non-recurring Gain/Loss Item | Amount (Million Yuan) | | :--- | :--- | | Fair Value Changes from Financial Assets Held for Trading, Derivative Financial Assets, etc. | 10.29 | | Gains/Losses from Entrusted Investments or Asset Management | 4.61 | | Government Grants Recognized in Current Profit/Loss | 1.46 | | Income Tax Impact | -2.50 | | **Total** | **14.15** | [Management Discussion and Analysis](index=7&type=section&id=Management%20Discussion%20and%20Analysis) [Industry and Main Business Overview](index=7&type=section&id=Industry%20and%20Main%20Business%20Overview) The company operates in chemical manufacturing, specializing in organosilicon fine chemicals like functional additives and phenylchlorosilanes for new materials, pharma, and electronics - According to the CSRC industry classification, the company belongs to 'C26 Chemical Raw Materials and Chemical Products Manufacturing'[24](index=24&type=chunk) - The company's main products include two major categories: - **Organosilicon functional additives**: such as hexamethyldisilazane and siloxanes from the methyl series; vinyl double-ended silanes and vinylsilazanes from the vinyl series - **Phenylchlorosilanes**: such as phenyltrichlorosilane and diphenyldichlorosilane[24](index=24&type=chunk)[25](index=25&type=chunk) [Core Competencies Analysis](index=8&type=section&id=Core%20Competencies%20Analysis) Core competencies include leading technology, comprehensive client solutions, strong R&D, integrated supply chain, circular economy, and established global brand recognition - The company possesses independently developed hexamethyldisilazane solvent-free patented technology and the only direct method production line for phenylchlorosilane in China, ensuring industry-leading product quality[26](index=26&type=chunk) - The company provides diversified product portfolio solutions to meet the customized needs of global large-scale organosilicon enterprises through its customer service team, fostering long-term stable client relationships[26](index=26&type=chunk) - The company has established multiple provincial research centers and collaborates with universities like Wuhan University on industry-academia-research projects, accumulating **45 patents**[27](index=27&type=chunk) - The company continuously strengthens the comprehensive utilization of by-products, develops green processes and clean production for a circular economy, enhancing resource utilization efficiency and profitability[27](index=27&type=chunk) [Discussion and Analysis of Operations](index=8&type=section&id=Discussion%20and%20Analysis%20of%20Operations) H1 2021 saw substantial revenue and net profit growth (both over **71%**) driven by strong downstream demand, with key projects like vinyl double-ended silane completed and others underway | Indicator | H1 2021 | YoY Growth | | :--- | :--- | :--- | | Operating Revenue | 414.39 Million Yuan | 71.37% | | Net Profit Attributable to Shareholders | 146.76 Million Yuan | 71.88% | | Net Profit Attributable to Shareholders (Excluding Non-recurring Items) | 132.61 Million Yuan | 55.26% | | Earnings Per Share | 0.94 Yuan | 28.77% | | Account | Change (%) | Reason for Change | | :--- | :--- | :--- | | Operating Revenue | 71.37% | Increased downstream market demand and significant growth in product sales | | Operating Cost | 90.28% | Increased sales volume and rising raw material prices led to higher costs | | Selling Expenses | -74.82% | Freight and other costs reclassified to operating costs under new revenue recognition standards | | R&D Expenses | 85.63% | Increased investment in R&D projects | | Financial Expenses | -102.73% | Exchange losses due to fluctuations in RMB and USD exchange rates | | Net Cash Flow from Operating Activities | -41.23% | Increased cash payments for goods purchased | - The company successfully completed the construction of production facilities for products such as vinyl double-ended silane and hexamethyldisiloxane, while projects like phenyl silicone resin, phenyl intermediates, and phenylchlorosilane Phase II are progressing as planned[28](index=28&type=chunk) [Analysis of Assets and Liabilities](index=10&type=section&id=Analysis%20of%20Assets%20and%20Liabilities) Total assets grew **2.50%** to **2.16 Billion Yuan**, with monetary funds decreasing due to investments, while accounts receivable, construction in progress, and prepaid equipment significantly increased | Asset/Liability Item | Period-end Balance (Million Yuan) | Change from Prior Year-end (%) | Primary Reason | | :--- | :--- | :--- | :--- | | Monetary Funds | 232.45 | -41.15% | Increased funds used for wealth management product purchases | | Accounts Receivable | 105.63 | 53.76% | Increased revenue led to a corresponding increase in accounts receivable | | Construction in Progress | 149.81 | 32.88% | Increased investment in ongoing projects | | Other Non-current Assets | 14.90 | 112.14% | Increased prepaid equipment payments | | Taxes Payable | 15.04 | 290.27% | Increased corporate income tax payable | - As of the end of the reporting period, the company's total restricted assets amounted to **65.45 Million Yuan**, including monetary funds for bank acceptance bill deposits and notes receivable pledged for bill issuance[35](index=35&type=chunk) [Potential Risks](index=12&type=section&id=Potential%20Risks) Key risks include intensified market competition, macroeconomic volatility, hazardous chemical safety, stricter environmental regulations, and new product R&D failure - The company faces intensified market competition risk from dominant industry players entering its main product segments, potentially leading to capacity expansion and price declines[38](index=38&type=chunk) - Operations involve various hazardous chemicals, posing a risk of safety production accidents due to improper handling or equipment malfunction[39](index=39&type=chunk) - With tightening environmental regulations, stricter future environmental standards may increase the company's environmental investments and operating costs[40](index=40&type=chunk) - New product R&D has long cycles and high costs; failure to develop or adapt to market demand would adversely impact operations[41](index=41&type=chunk) [Corporate Governance](index=13&type=section&id=Corporate%20Governance) [Shareholders' Meeting and Profit Distribution](index=13&type=section&id=Shareholders%27%20Meeting%20and%20Profit%20Distribution) The 2020 Annual Shareholders' Meeting approved the annual report and profit distribution, with no interim profit distribution or capital reserve capitalization planned - The company convened its 2020 Annual Shareholders' Meeting on May 18, 2021, approving seven proposals including the '2020 Annual Report and its Summary' and the '2020 Profit Distribution Plan'[43](index=43&type=chunk) - The company's proposed interim profit distribution plan is no distribution and no capitalization from capital reserves[45](index=45&type=chunk) [Environmental and Social Responsibility](index=14&type=section&id=Environmental%20and%20Social%20Responsibility) [Environmental Information](index=14&type=section&id=Environmental%20Information) As a key polluter, the company strictly complies with environmental regulations, with all emissions meeting standards and no penalties incurred, operating effective treatment systems and emergency plans | Pollutant | Discharge Method | Total Discharge (Tons) | Approved Discharge (Tons) | Exceedance | | :--- | :--- | :--- | :--- | :--- | | **Wastewater** | | | | | | COD | Intermittent Discharge | 3.02 | 12.87 | No | | NH3-N | Intermittent Discharge | 0.19 | 0.59 | No | | **Exhaust Gas** | | | | | | VOC | Continuous Discharge | 3.96 | 14.94 | No | | Hydrogen Chloride | Continuous Discharge | 2.85 | 6.96 | No | - The company has established a wastewater treatment system (MVR evaporation desalination and biochemical treatment) and incineration facilities for waste gas, liquid, and residue, ensuring compliance with discharge standards[49](index=49&type=chunk) - The company has prepared and filed its 'Emergency Response Plan for Environmental Incidents' and formulated a self-monitoring plan for environmental compliance, strictly conducting monitoring as required[51](index=51&type=chunk)[52](index=52&type=chunk) - During the reporting period, the company received no administrative penalties for environmental issues[53](index=53&type=chunk) [Significant Matters](index=16&type=section&id=Significant%20Matters) [Fulfillment of Commitments](index=16&type=section&id=Fulfillment%20of%20Commitments) Actual controllers, shareholders, and management strictly fulfilled all IPO commitments, including share lock-up and price stabilization measures, with timely and rigorous execution - Controlling shareholders, actual controllers, and other major shareholders committed not to transfer their pre-IPO shares for **36 months** from the company's listing date (September 1, 2020)[55](index=55&type=chunk)[57](index=57&type=chunk)[60](index=60&type=chunk)[61](index=61&type=chunk) - The company formulated a stock price stabilization plan for three years post-listing: if the company's stock closing price falls below the latest net asset per share for **20 consecutive trading days**, measures such as company buybacks, actual controller share increase, and director/supervisor/senior management share increase will be initiated[65](index=65&type=chunk)[66](index=66&type=chunk)[68](index=68&type=chunk)[69](index=69&type=chunk) [Integrity Status and Significant Transactions](index=22&type=section&id=Integrity%20Status%20and%20Significant%20Transactions) The company and its controlling shareholders maintained good integrity, with no dishonesty, major lawsuits, or significant related-party/asset transactions - During the reporting period, the company, its controlling shareholders, and actual controllers had no instances of dishonesty, unfulfilled court judgments, or significant overdue debts[75](index=75&type=chunk) - During the reporting period, the company had no significant litigation or arbitration matters[75](index=75&type=chunk) - The company did not engage in significant related-party transactions, major contracts, trusteeships, contracting, leasing, or significant asset and equity sales[76](index=76&type=chunk)[78](index=78&type=chunk)[37](index=37&type=chunk) [Share Changes and Shareholder Information](index=24&type=section&id=Share%20Changes%20and%20Shareholder%20Information) [Share Capital Changes and Shareholder Information](index=24&type=section&id=Share%20Capital%20Changes%20and%20Shareholder%20Information) As of June 30, 2021, share capital was unchanged with **9,850** shareholders; Chu Lin is the largest at **45.99%**, and key shareholders are parties acting in concert - During the reporting period, the company's total share capital and equity structure remained unchanged[80](index=80&type=chunk) - As of the end of the reporting period, the company had **9,850** common shareholders[81](index=81&type=chunk) | Shareholder Name | Shares Held at Period-end (Shares) | Proportion (%) | | :--- | :--- | :--- | | Chu Lin | 71,534,613 | 45.99 | | Hongta Innovation (Kunshan) Venture Capital Co., Ltd. | 19,643,310 | 12.63 | | Hongta Innovation Investment Co., Ltd. | 11,294,790 | 7.26 | | Chu Yaxian | 9,821,657 | 6.31 | | BOCOM Schroders Advanced Manufacturing Mixed Fund | 3,062,039 | 1.97 | - Explanation of shareholder relationships: Chu Yajun, Chu Lin, and Chu Yaxian are parties acting in concert; Hongta Innovation (Kunshan) Venture Capital Co., Ltd. is a wholly-owned subsidiary of Hongta Innovation Investment Co., Ltd.[85](index=85&type=chunk) [Preferred Shares Information](index=27&type=section&id=Preferred%20Shares%20Information) [Preferred Shares Status](index=27&type=section&id=Preferred%20Shares%20Status) During the current reporting period, the company had no preferred shares - During the reporting period, the company had no preferred shares[89](index=89&type=chunk) [Bonds Information](index=27&type=section&id=Bonds%20Information) [Bonds Status](index=27&type=section&id=Bonds%20Status) During the current reporting period, the company had no corporate bonds, company bonds, non-financial enterprise debt financing instruments, or convertible corporate bonds - During the reporting period, the company had no corporate bonds, company bonds, non-financial enterprise debt financing instruments, or convertible corporate bonds[90](index=90&type=chunk) [Financial Report](index=28&type=section&id=Financial%20Report) [Financial Statements](index=28&type=section&id=Financial%20Statements) As of June 30, 2021, total assets were **2.16 Billion Yuan** with a **5.98%** asset-liability ratio, while H1 revenue reached **414.39 Million Yuan** and net profit **146.76 Million Yuan**, with significant cash outflows from investing and financing activities Key Balance Sheet Items (June 30, 2021) | Item | Amount (Million Yuan) | | :--- | :--- | | **Assets** | | | Monetary Funds | 232.45 | | Financial Assets Held for Trading | 1,287.43 | | Accounts Receivable | 105.63 | | Inventories | 103.47 | | Construction in Progress | 149.81 | | **Total Assets** | **2,157.17** | | **Liabilities and Owners' Equity** | | | Notes Payable | 66.40 | | **Total Liabilities** | **128.91** | | **Total Owners' Equity** | **2,028.26** | Key Income Statement Items (Jan-Jun 2021) | Item | Amount (Million Yuan) | | :--- | :--- | | I. Operating Revenue | 414.39 | | Less: Operating Cost | 239.79 | | R&D Expenses | 12.61 | | Investment Income | 9.57 | | Fair Value Change Gains | 10.29 | | II. Operating Profit | 168.24 | | III. Total Profit | 169.12 | | IV. Net Profit | 146.76 | Key Cash Flow Statement Items (Jan-Jun 2021) | Item | Amount (Million Yuan) | | :--- | :--- | | Net Cash Flow from Operating Activities | 59.68 | | Net Cash Flow from Investing Activities | -144.95 | | Net Cash Flow from Financing Activities | -80.95 | | Net Increase in Cash and Cash Equivalents | -168.84 | [Notes to Financial Statements](index=39&type=section&id=Notes%20to%20Financial%20Statements) Financial notes detail **1.29 Billion Yuan** in trading financial assets (structured deposits), accounts receivable provisions, **145.00 Million Yuan** in construction in progress for key projects, and significant related-party transactions for materials and sales - The period-end balance of financial assets held for trading was **1.29 Billion Yuan**, with structured deposits accounting for **1.29 Billion Yuan**[183](index=183&type=chunk) - The period-end balance of accounts receivable was **112.00 Million Yuan**, with a bad debt provision of **6.05 Million Yuan** calculated by aging portfolio, where the provision rate for accounts receivable within one year is **5%**[194](index=194&type=chunk)[195](index=195&type=chunk) - The period-end balance of construction in progress was **150.00 Million Yuan**, primarily including vinyl projects (**92.97 Million Yuan**) and phenyl silicone resin projects (**52.43 Million Yuan**)[231](index=231&type=chunk) Key Related-Party Transactions (Current Period) | Related Party | Related Transaction Content | Amount (Million Yuan) | | :--- | :--- | :--- | | Hubei Xingrui Silicon Material Co., Ltd. | Material Purchase | 34.84 | | Shandong Dongyue Organosilicon Material Co., Ltd. | Material Purchase | 2.68 | | Shandong Dongyue Organosilicon Material Co., Ltd. | Product Sales | 6.34 | | Zhejiang Runhe Organosilicon New Material Co., Ltd. | Product Sales | 6.18 | | Hubei Xingrui Silicon Material Co., Ltd. | Product Sales | 3.97 |
新亚强(603155) - 2020 Q4 - 年度财报
2021-04-25 16:00
2020 年年度报告 四、 公司负责人初亚军、主管会计工作负责人宋娜及会计机构负责人(会计主管人员)刘仕娟声 明:保证年度报告中财务报告的真实、准确、完整。 五、 经董事会审议的报告期利润分配预案或公积金转增股本预案 根据公司盈利情况、未分配利润余额情况及现金流状况,结合公司未来投资和业务发展计划 ,公司2020年度利润分配方案拟以总股本155,560,000股为基数,向全体股东按每10股派发现金红 利5.50元(含税),共计派发现金红利85,558,000.00元(含税)。本年度不送红股,不进行资本公 积金转增股本。 六、 前瞻性陈述的风险声明 公司代码:603155 公司简称:新亚强 新亚强硅化学股份有限公司 2020 年年度报告 1 / 154 2020 年年度报告 重要提示 三、 中审众环会计师事务所(特殊普通合伙)为本公司出具了标准无保留意见的审计报告。 √适用 □不适用 本报告中所涉及到的未来计划、发展战略等前瞻性描述不构成公司对投资者的实质承诺,敬 请投资者注意投资风险。 七、 是否存在被控股股东及其关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况? 否 九、 是 ...
新亚强(603155) - 2021 Q1 - 季度财报
2021-04-25 16:00
公司代码:603155 公司简称:新亚强 新亚强硅化学股份有限公司 2021 年第一季度报告 1 / 14 | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 6 | | 四、 | 附录 | 8 | 2021 年第一季度报告 一、 重要提示 二、 公司基本情况 2.1 主要财务数据 非经常性损益项目和金额 2021 年第一季度报告 单位:元 币种:人民币 本报告期末 上年度末 本报告期末比上年度末增 减(%) 总资产 2,153,698,794.33 2,104,591,662.00 2.33 归属于上市公司 股东的净资产 2,037,451,420.28 1,966,551,330.32 3.61 年初至报告期末 上年初至上年报告期末 比上年同期增减(%) 经营活动产生的 现金流量净额 -12,362,668.78 42,012,649.27 -129.43 年初至报告期末 上年初至上年报告期末 比上年同期增减(%) 营业收入 193,322,636.11 111,309,972.17 73.68 归属于上市公司 股 ...
新亚强(603155) - 2020 Q3 - 季度财报
2020-10-28 16:00
公司代码:603155 公司简称:新亚强 新亚强硅化学股份有限公司 2020 年第三季度报告 1 / 17 | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 7 | | 四、 | 附录 | 9 | 2020 年第三季度报告 2020 年第三季度报告 一、 重要提示 二、 公司基本情况 2.1 主要财务数据 单位:元 币种:人民币 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增 | | | --- | --- | --- | --- | --- | --- | | | | | | 减(%) | | | 总资产 | 2,051,943,094.94 | 714,029,269.95 | | | 187.38 | | 归属于上市公司 | 1,932,032,614.89 | 665,214,929.16 | | | 190.44 | | 股东的净资产 | | | | | | | | 年初至报告期末 | 上年初至上年报告期末 | | 比上年同期增减 | | | | (1-9 月) | (1-9 月) | | ...